Cemiplimab in High-risk or Locally Advanced Luminal and Triple Negative Breast Cancer
Clinical trial NCT04243616 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04243616
- Sponsor
- Medical College of Wisconsin
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-05
- Primary completion
- 2025-08-11
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.